HOME >> MEDICINE >> NEWS
Predicting the risk of rheumatoid arthritis for early arthritis patients

Marked by chronic inflammation of the joints and tissue, rheumatoid arthritis (RA) is a painful and potentially disabling autoimmune disease. A wealth of research supports early aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) as the best course for preventing joint damage and avoiding the fate of a wheelchair. Still, the use of DMARDs, even the widely prescribed and generally safe methotrexate, brings the risk of liver damage and other serious complications.

Among those who seek out a doctor's help for joint pain and stiffness, the most common diagnosis is undifferentiated arthritis (UA), or arthritic symptoms that do not add up to a specific arthritic disease. Spontaneous remission occurs in 40 to 50 percent of UA sufferers, while about one-third develop RA. Physicians often face the tough choice of whether to initiate DMARD therapy immediately or to wait and see. To guide individual treatment decisions, researchers with the Early Arthritis Clinic at Leiden University Medical Center, The Netherlands, have found a formula to help determine whether patients who present with UA are likely to progress to RA. The February 2007 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis) features their simple, reliable prediction rule for disease outcome.

Starting with clinical data for over 1,700 arthritis patients, the Leiden team identified 570 patients with recent-onset UA and monitored their disease for one year. At the culmination of follow-up, 177 of the original UA patients fulfilled the diagnostic criteria for RA and 150 had achieved remission; the remaining 94 had been diagnosed with another rheumatologic disease. Through a combination of questionnaires, physical examination, and blood samples, the team identified 9 clinical variables with independent predictive value for RA: sex, age, localization of symptoms, mornin
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
30-Jan-2007


Page: 1 2

Related medicine news :

1. Predicting danger of flu pandemic rests on differences in affected population, says O.R. Forum
2. Predicting the quality of life for older adults
3. Predicting an answer to the threat of flooding
4. Predicting outcomes for kidney transplant patients
5. Predicting successful outcomes in living-donor liver transplants
6. Predicting cardiovascular problems in liver transplant patients
7. Predicting the risk of death in patients with known coronary artery disease
8. Predicting the future of primary care in England
9. Predicting the outcome of drug-induced liver disease
10. Predicting serious cardiac outcomes
11. Green tea compound may be a therapy for people with rheumatoid arthritis

Post Your Comments:
(Date:3/5/2015)... JACKSON, MS (PRWEB) March 05, 2015 ... “The Basics and Beyond,” leaders in addiction treatment met ... and updates in best clinical practices. Among the numerous ... M.D. , who will address the role that pain ... epidemic and new evidence-based treatment options. , "It is ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Califia ... leader in the natural products coffee drinks category[1], today ... Products Expo West in Anaheim, Calif. Concentrated Cold ... concept, Califia Café, which democratizes the next wave of ... ingredients they need to become their own baristas. ...
(Date:3/5/2015)... March 05, 2015 Supply & Demand ... listing of “Pros to Know” in the supply chain ... members of MEBC’s leadership team were included on this ... and received this award due to their hard work, ... methods for meeting and resolving client needs and challenges. ...
(Date:3/5/2015)... March 05, 2015 INTEGRATED Healthcare ... organizations to participate in its 2015 Children’s Hospitals ... executive and director-level positions, and the survey results ... year’s report featured data on 60 executive and ... healthcare organizations and 7 subsidiary children’s hospitals. Additionally, ...
(Date:3/5/2015)... Today, Earth Source Organics (ESO) ... pollution-free electricity through a partnership with national Clean ... Arcadia Power Clean Energy Partner, ESO now meets ... requirements, joining national brands such as Whole Foods, ... Earth Source Organics joins a growing community of ...
Breaking Medicine News(10 mins):Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2
(Date:3/5/2015)... -- AMRI (NASDAQ: AMRI ) announced today that ... of VP of International Sales, effective immediately. He reports ... Global Sales and Marketing. In this ... in an effort to increase worldwide customer value and ... will drive strategy for sales and marketing efforts across ...
(Date:3/5/2015)... WASHINGTON , March 5, 2015 ... applauds the Food and Drug Administration,s (FDA) approval ... (nivolumab). Opdivo and other immunotherapy treatments add another ... by harnessing the power of a patient,s own ... drug has been approved specifically for patients with ...
(Date:3/5/2015)... 05, 2015 Research and Markets ... the "Global Pharma US & EU Outlook ... Major Role In Shaping Up Business for Large ... Strategy Diversification Divested: Productivity measurements, ... position- Will accelerate Next wave of targeted acquisition ...
Breaking Medicine Technology:AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3
Cached News: